Literature DB >> 18983883

Infectious bursal disease subviral particles displaying the foot-and-mouth disease virus major antigenic site.

Michelle Rémond1, Bruno Da Costa, Sabine Riffault, Satya Parida, Emmanuel Breard, Françoise Lebreton, Stephan Zientara, Bernard Delmas.   

Abstract

An antigen delivery system based on subviral particles formed by the self-assembly of the capsid protein of infectious bursal disease virus and carrying foreign peptides at the top of the projection domain was investigated. We report here the effective insertion of the foot-and-mouth disease virus (FMDV) immunodominant epitope in one of the four external loops of the subviral particles. Out of the two loops tested, one of them tolerated an insert of 12 amino acids without disrupting the subviral particle assembly. The subviral particles reacted with neutralizing FMDV type O1 monoclonal and polyclonal antibodies and elicited a neutralizing antibody response in immunized mice. Furthermore, we found that they have the potential for the detection of FMDV antibodies in a competitive ELISA for diagnostic.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18983883     DOI: 10.1016/j.vaccine.2008.10.036

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  A potential nanobiotechnology platform based on infectious bursal disease subviral particles.

Authors:  Omid Taghavian; Manoj K Mandal; Nicole F Steinmetz; Stefan Rasche; Holger Spiegel; Rainer Fischer; Stefan Schillberg
Journal:  RSC Adv       Date:  2012-01-09       Impact factor: 3.361

2.  Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.

Authors:  Elena Pascual; Carlos P Mata; Josué Gómez-Blanco; Noelia Moreno; Juan Bárcena; Esther Blanco; Ariel Rodríguez-Frandsen; Amelia Nieto; José L Carrascosa; José R Castón
Journal:  J Virol       Date:  2014-12-17       Impact factor: 5.103

3.  Recombinant infectious bursal disease virus carrying hepatitis C virus epitopes.

Authors:  Chitra Upadhyay; Arun Ammayappan; Deendayal Patel; Imre Kovesdi; Vikram N Vakharia
Journal:  J Virol       Date:  2010-11-24       Impact factor: 5.103

4.  Immunogenicity evaluation of MS2 phage-mediated chimeric nanoparticle displaying an immunodominant B cell epitope of foot-and-mouth disease virus.

Authors:  Guoqiang Wang; Yunchao Liu; Hua Feng; Yumei Chen; Suzhen Yang; Qiang Wei; Juan Wang; Dongmin Liu; Gaiping Zhang
Journal:  PeerJ       Date:  2018-05-23       Impact factor: 2.984

5.  A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challenge.

Authors:  Robert B Mandell; Ramesh Koukuntla; Laura J K Mogler; Andrea K Carzoli; Alexander N Freiberg; Michael R Holbrook; Brian K Martin; William R Staplin; Nicholas N Vahanian; Charles J Link; Ramon Flick
Journal:  Virology       Date:  2009-11-24       Impact factor: 3.616

6.  Requirements for improved vaccines against foot-and-mouth disease epidemics.

Authors:  Jong-Hyeon Park
Journal:  Clin Exp Vaccine Res       Date:  2013-01-15

7.  Immunity of foot-and-mouth disease serotype Asia 1 by sublingual vaccination.

Authors:  Hao-tai Chen; Yong-sheng Liu
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.